OKAVA Press Releases - EIN Presswire - Press Release Distribution Service

Published on December 3, 2025 - 07:55 GMT

OKAVA Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First GLP-1 Weight Loss Therapy for Pets

SAN FRANCISCO, CA, UNITED STATES, December 2, 2025 /⁨EINPresswire.com⁩/ -- OKAVA Pharmaceuticals is a clinical-stage company developing medicines to enable dogs and cats to live longer, healthier lives. Today, the company announced that the first cat has …

Distribution channels: Culture, Society & Lifestyle ...

Published on March 3, 2025 - 14:48 GMT

Okava Collaborates With Undisclosed Strategic Partner to Advance OKV-1001 for Human Use

Strategic partnership ensures that OKV-1001 reaches its full potential—advancing care for both pets and people SAN FRANCISCO, CA, UNITED STATES, March 3, 2025 /⁨EINPresswire.com⁩/ -- OKAVA Pharmaceuticals, Inc. (“Okava,” or “the Company”), a clinical …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 13, 2025 - 11:30 GMT

Okava Recognizes National Cat Health Month

Okava leads in the research and development of new therapies for the management of feline diabetes and obesity SAN FRANCISCO, CA, UNITED STATES, February 13, 2025 /⁨EINPresswire.com⁩/ -- Okava Pharmaceuticals, Inc. ("Okava" or "the Company…

Distribution channels: Healthcare & Pharmaceuticals Industry ...